Company Profile

Immunova Therapeutics LLC
Profile last edited on: 10/13/2023      CAGE: 986W1      UEI: J8RSMABQPN95

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2020
First Award
2022
Latest Award
2024
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

605 East Huntington Drive Suite 103
Monrovia, CA 91016
Location: Single
Congr. District: 31
County: Los Angeles

Public Profile

Describing the firm as working in the arena of Cancer Immunotherapy (CAR-T, TCR-T, Antibody, Vaccines etc), location is an office-type complex with minimal detail accessible re. firm's operations, work focus etc.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1741798944 2 NIH $1,001,030
Project Title: Development of CD4 TCR-engineered T cell immunotherapy in triple-negative breast cancer
2023 2 NIH $2,000,000
Project Title: Development of a Therapeutic SAPNANO-ESO Vaccine for Prostate Cancer

Key People / Management

  Rongfu Wang

  Yicheng Wang

Company News

There are no news available.